Ma J, Chen Y, Song J, Ruan Q, Li L, Luo L
Proc Natl Acad Sci U S A. 2025; 122(5):e2413719122.
PMID: 39883840
PMC: 11804616.
DOI: 10.1073/pnas.2413719122.
Ittiprasert W, Brindley P
Trends Parasitol. 2024; 40(11):1016-1028.
PMID: 39426911
PMC: 11560492.
DOI: 10.1016/j.pt.2024.09.010.
van den Bosch Q, Kilic E, Brosens E
Invest Ophthalmol Vis Sci. 2024; 65(10):26.
PMID: 39163035
PMC: 11346061.
DOI: 10.1167/iovs.65.10.26.
Casey M, Chan P, Li Q, Zu J, Jette C, Kohler M
Cell Rep. 2024; 43(8):114559.
PMID: 39078737
PMC: 11404834.
DOI: 10.1016/j.celrep.2024.114559.
Yu Q, Li W, Liang M, Li G, Wu Z, Long J
Molecules. 2024; 29(3).
PMID: 38338377
PMC: 10856188.
DOI: 10.3390/molecules29030633.
Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies.
Zarrabi A, Perrin D, Kavoosi M, Sommer M, Sezen S, Mehrbod P
Cancers (Basel). 2023; 15(21).
PMID: 37958442
PMC: 10650215.
DOI: 10.3390/cancers15215269.
Drug-Induced Cardiotoxicity in Children During the Past 30 Years: A Bibliometric Study and Visualization Analysis.
Wu M, Yang Y, Cao M, Liu T, Tian Y, Zhao Z
Med Sci Monit. 2023; 29:e938673.
PMID: 36806177
PMC: 9951546.
DOI: 10.12659/MSM.938673.
Addressing blood-brain-tumor-barrier heterogeneity in pediatric brain tumors with innovative preclinical models.
Morris E, Daignault-Mill S, Stehbens S, Genovesi L, Lagendijk A
Front Oncol. 2023; 13:1101522.
PMID: 36776301
PMC: 9909546.
DOI: 10.3389/fonc.2023.1101522.
Shedding Light on the Drug-Target Prediction of the Anti-Inflammatory Peptide P with Bioinformatics Tools.
Lima C, Eto S, Lopes-Ferreira M
Pharmaceuticals (Basel). 2022; 15(8).
PMID: 36015142
PMC: 9412873.
DOI: 10.3390/ph15080994.
Zebrafish-An Optimal Model in Experimental Oncology.
Kwiatkowska I, Hermanowicz J, Iwinska Z, Kowalczuk K, Iwanowska J, Pawlak D
Molecules. 2022; 27(13).
PMID: 35807468
PMC: 9268704.
DOI: 10.3390/molecules27134223.
Modeling Brain Tumors: A Perspective Overview of and Organoid Models.
Antonica F, Aiello G, Soldano A, Abballe L, Miele E, Tiberi L
Front Mol Neurosci. 2022; 15:818696.
PMID: 35706426
PMC: 9190727.
DOI: 10.3389/fnmol.2022.818696.
Disease modeling by efficient genome editing using a near PAM-less base editor in vivo.
Rosello M, Serafini M, Mignani L, Finazzi D, Giovannangeli C, Mione M
Nat Commun. 2022; 13(1):3435.
PMID: 35701478
PMC: 9198099.
DOI: 10.1038/s41467-022-31172-z.
Orthotopic Transplantation of Human Paediatric High-Grade Glioma in Zebrafish Larvae.
Larsson S, Kettunen P, Caren H
Brain Sci. 2022; 12(5).
PMID: 35625011
PMC: 9139401.
DOI: 10.3390/brainsci12050625.
Patient-Derived Xenotransplant of CNS Neoplasms in Zebrafish: A Systematic Review.
Sarmiento B, Callegari S, Ghotme K, Akle V
Cells. 2022; 11(7).
PMID: 35406768
PMC: 8998145.
DOI: 10.3390/cells11071204.
Pediatric Chemotherapy Drugs Associated With Cardiotoxicity.
Hitawala G, Jain E, Castellanos L, Garimella R, Akku R, Chamavaliyathil A
Cureus. 2022; 13(11):e19658.
PMID: 34976454
PMC: 8679581.
DOI: 10.7759/cureus.19658.
MicroRNA-21 Plays Multiple Oncometabolic Roles in Colitis-Associated Carcinoma and Colorectal Cancer via the PI3K/AKT, STAT3, and PDCD4/TNF-α Signaling Pathways in Zebrafish.
Lai C, Yeh K, Liu B, Chang T, Chang C, Liao Y
Cancers (Basel). 2021; 13(21).
PMID: 34771727
PMC: 8583575.
DOI: 10.3390/cancers13215565.
Future Match Making: When Pediatric Oncology Meets Organoid Technology.
Barbet V, Broutier L
Front Cell Dev Biol. 2021; 9:674219.
PMID: 34327198
PMC: 8315550.
DOI: 10.3389/fcell.2021.674219.
Tipping the Scales With Zebrafish to Understand Adaptive Tumor Immunity.
Miao K, Kim G, Meara G, Qin X, Feng H
Front Cell Dev Biol. 2021; 9:660969.
PMID: 34095125
PMC: 8173129.
DOI: 10.3389/fcell.2021.660969.
Preclinical In Vivo Modeling of Pediatric Sarcoma-Promises and Limitations.
Imle R, Kommoss F, Banito A
J Clin Med. 2021; 10(8).
PMID: 33918045
PMC: 8069549.
DOI: 10.3390/jcm10081578.
and Pediatric Brain Tumor Models: An Overview.
Li Z, Langhans S
Front Oncol. 2021; 11:620831.
PMID: 33869004
PMC: 8047472.
DOI: 10.3389/fonc.2021.620831.